Xinyan Tang

Statistics

Publications

Citations

237

H-Index

Active since

2020

Affiliations

Denali Therapeutics (United States)(Current)

Massachusetts General Hospital

Xinyan Tang is an author at Denali Therapeutics (United States) specializing in neuroinflammation, neurodegenerative disorders, and amyotrophic lateral sclerosis.

Publications per year

2020–2025

Publications

Longitudinal biomarkers in amyotrophic lateral sclerosis

Yuda Zhu, Jennifer Hsiao‐Nakamoto, Xinyan Tang et al. · Annals of Clinical and Translational Neurology · 2020 · 114 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Safety, pharmacokinetics and target engagement of novel <scp>RIPK1</scp> inhibitor <scp>SAR443060</scp> (<scp>DNL747</scp>) for neurodegenerative disorders: Randomized, <scp>placebo‐controlled</scp>, <scp>double‐blind</scp> phase I/Ib studies in healthy subjects and patients

Maurits F. J. M. Vissers, Jules A. A. C. Heuberger, Geert Jan Groeneveld et al. · Clinical and Translational Science · 2022 · 102 citations · Full text

Medicine, Neurology, Pharmacology +17

Single-cell transcriptomic and functional studies identify glial state changes and a role for inflammatory RIPK1 signaling in ALS pathogenesis

Matija Zelic, Anna Blazier, Fabrizio Pontarelli et al. · Immunity · 2025 · 21 citations · Full text

Life Sciences, Neurology, Neuroscience +17

1–3 of 3